Together, these data indicated that metronomic Celecoxib treatment exerted an inhibitory effect on the invasive property of HCC cells by reducing COX-2/PGE2 independent, NFκB-dependent MMP-9 expression. The gene discussed is PTGS2; the disease is hepatocellular carcinoma.